An unusual ease is described of a patient with both anti-glomerular basement membrane (GBM) disease and anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity (MPO-ANCA) presenting with acute renal failure. Four years before a seronegative arthritis of the left wrist was diagnosed. Tests for ANCA by indirect immunofluorescence were repeatedly negative. The diagnosis was made by renal biopsy and by testing the serum with specific enzyme-linked immunosorbent assays (ELISA) for MPO-ANCA and anti-GBM antibodies. To our knowledge, this is the first patient presenting with such findings in the Dutch literature.
Introduction
In anti-glomerular basement membrane (G B M ) disease autoantibodies are found in serum directed against an epitope within the globular domain of type IV collagen of glomerular, distal tubular, and alveolar basement membranes (Goodpasture antigen). Most patients present with signs and symptoms of a rapidly progressive
2, Case report
A 49-year-old woman was admitted to hospital with a 4-week history of progressive malaise, nau sea, vomiting and haematuria. There was also continuous retrosternal pain, not related to physi cal exercise or posture. Four years before admis sion a chronic monarthritis of the left wrist devel oped. Two years later a synovectomy with resec tion of the distal ulna was performed, showing a chronic aspecific synovitis. Two months before admission laboratory tests showed normal renal function (serum creatinine 75 ¿imol/1; normal 60-100 ¿¿mol/1). Six weeks before admission treatment with sulphasalazine 1000 mg 2dd was started because of an arthritis of the right ankle. One week later she noticed haematuria, with normal urinary output. Respiratory tract com plaints (sinus pain, nasal discharge, cough, haemoptysis) were absent. She smoked 5 cigarettes a day. No history of familial renal or rheumatological disease was present. Physical ex amination revealed a pale woman with a blood pressure of 150/90 mmHg. Neck veins were not distended; the lungs were clear. Pericardial rub bing was present on cardiac examination. Abdom inal examination revealed no abnormalities.
Laboratory tests showed an erythrocyte sedi mentation rate > 140 mm, a haemoglobin con centration of 5.7 m m o l/I, thrombocytosis of 329 X 109/1 and a normal white cell and differential count. The urinary protein excretion was 1.1 g/24 h. The sediment contained > 100 erythrocytes, many rust-cylinders and a few erythrocyte-cylinders, but no leucocytes. Urine culture was nega tive. The serum creatinine concentration had risen to 866 ¿¿mol/l; serum urea concentration was 24.7 mmol/1. The calculated endogenous creati nine clearance was 3 m l/m in . Serum sodium, potassium, blood glucose, liver functions and L D H were normal. Serum calcium was 2.53 mmol/1, phosphorus 1.69 mmol/1 and serum al bumin 34 g/1. Protein electrophoresis revealed no paraproteins. Tests for cryoglobulins, rheuma toid factors (Waaler-Rose and latex), antinuclear and antiperinuclear antibodies were negative. Complement factors C3 (1.4 g/1) and C4 (0.31 g/1) were normal, while C3d was elevated (285%).
Tests for anti-neutrophil cytoplasmic antibod ies by indirect immunofluorescence using a rou tine procedure (assay previously described by van de Woude et al. [10] ) were negative twice (per formed at Groot Ziekengasthuis and at the Cen tral Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB), Amsterdam), as were tests performed on a serum sample drawn 2 weeks later (during treatment). However, the sandwich (catching) ELISA (as previously de scribed by Goldschmeding et a l [11] , results ex pressed as (arbitrary) ELISA units (EU), cut-off level 35 EU ) with monoclonal antibodies, used for testing the specificity of antibodies, was posi tive twice (215 and 217 EU), with specificity for anti-myeloperoxidase. A test performed on a serum sample drawn 2 weeks later (during treat ment) was also positive for MPO-ANCA, with a decrease in antibody level (54 EU), All samples were also positive for MPO-ANCA in a direct ELISA using plates coated with purified antigen, thereby excluding false-positive results based on cross-reaction with monoclonal antibodies used in the catching E LISA (tests performed at CLB).
Cardiac sonography showed some pericardial effusion, due to pericarditis. Abdominal sonogra phy showed normal-sized kidneys (length right kidney 11 cm, left kidney 10 cm), with increased echographic density of the renal cortex, equal to that of the adjacent liver and spleen. There was no evidence of hydronephrosis. X-thorax was nor mal. Percutaneous renal biopsy showed in nearly all glomeruli a recent extracapillary proliferation mixed with fibrin deposits (Fig. 1) . One glomeru lus showed recent destruction of loops, while total glomerular destruction with a granuloma tous reaction occurred in another. Some Bow man's capsules and tubular basement membranes were disrupted, with extensive necrosis of tubular epithelium. Intracapillary proliferation was not present. No signs of vasculitis could be found. The biopsy material for immunofluorescence did not contain glomeruli.
By indirect immunofluorescence on frozen 
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with positive anti-MPO E L IS A has been de scribed before: Weber et al. [5] detected low titres of anti-MPO antibodies in 7 out of 23 patients with Goodpasture's syndrome or anti-G B M glomerulonephritis. In these patients indi rect IF for A N C A was negative as in ours.
A possible explanation for the simultaneous production of both types of antibodies might be that anti-GBM antibody production starts after injury to the G B M by ANCA-associated glomeru lonephritis. The age of our patient, being nearer to that of patients with A N C A alone (sixth decade) as opposed to patients with anti-GBM alone (third decade), would support this hypothe sis [3, 8] » This is also in accordance with the study of O 'Donoghue et al. [4] who reported a strong association of double positives with female sex and (higher) age as opposed to patients with anti-GBM disease alone. In our patient the titre of anti-GBM antibodies was rather low. This is in accordance with Bosch et al. who detected an inverse relationship between anti-GBM antibod ies and A N C A titres [3] , As mentioned above, the assay for A N C A by indirect immunofluorescence in our patient was negative twice. In the study by Bosch et al. [3] a diffuse nuclear immunostaining pattern with ad ditional endonuclear bands was seen in the indi rect IF tests of nearly all patients with anti-MPO antibodies. The most probable explanation for this discrepancy is a difference in the indirect immunofluorescence detection technique for A N C A . IIF tests in our patient were performed on ethanol-fixed granulocytes. It has been shown that anti-MPO positive sera produce a perinu clear staining pattern on ethanol-fixed granulo cytes and a cytoplasmic staining pattern on for malin-fixed granulocytes [14] . Moreover, it has been demonstrated that anti-MPO sera that are negative on ethanol-fixed granulocytes produce a cytoplasmic staining pattern on granulocytes when cross-linking fixatives are used [15] . Therefore a probable explanation for the negative IIF test in our patient could be the loss of antigen and/or relevant epitopes during ethanol fixation, in which case a IIF test using formalin-fixed granulocytes might be a more reliable alternative.
It has been concluded that in anti-GBM dis ease A N C A may represent a serological marker of good (renal) prognosis. In the study by Bosch et al., 4 out of 11 patients (36%) with both ANCA and anti-GBM antibodies initially on dial ysis recovered satisfactory renal function. Three patients died (27%). In contrast, all 13 survivors with anti-GBM antibodies alone still required dialysis support after treatment, while 9 patients (41%) died [3] . In our patient there is no indica tion for recovery of renal function. This is in accordance with the study by O 'Donoghue et al. [4] who found a poor outcome in the double positive group (11 patients) with significant mor tality (4 patients, 36%) and irreversible renal failure (100% requiring dialysis with 9% inde pendent renal function at 3 months). O f 53 pa tients with anti-GBM alone 34 (64%) required dialysis, 23 (44%) having independent renal func tion at 3 months. The differences in renal prog nosis in the afore-mentioned studies might at least partly be due to differences in age between the study populations, the patients of Bosch (mean age 59 years) being considerably younger than those of O 'Donoghue (mean age 73 years). Weber et al. also reported a poor renal prognosis for patients with combined MPO-ANCA and anti-GBM similar to that for patients without ANCA antibodies [5] . In our patient because of developing thrombo cytopenia combination therapy was stopped after 3 weeks. Since patients with rapidly progressive glomerulonephritis may respond after 4 weeks [16] , it cannot be excluded that renal recovery might have occurred if treatment with cyclophos phamide a n d /o r plasmapheresis could have been continued. However, Herody et al., among others, concluded in their study of patients with anti-GBM disease that creatininaemia over 600 /¿mol/1 and circulating anti-GBM antibodies de tected by immunofluorescence were features which indicated an unfavourable renal course [1] .
More extensive extrarenal features in patients with combined A N C A and anti-GBM antibodies have been reported. The development of pul monary disease seems significantly associated with smoking [1, 4] . As for the interpretation of our patient's arthritis, it is known that rheumatic manifestations often precede a fulminant course in systemic vasculitis [17] . Furthermore, A N C A occur in rheumatoid arthritis (RA): Cambridge et al. detected anti-MPO antibodies in 12% of pa tients with R A [18] . We were not able to find references pointing to a possible association be tween anti-GBM disease and arthritis in the liter ature. Therefore, at present it can neither be demonstrated nor ruled out that the seronegative arthritis in our patient is an extrarenal manifesta tion of anti-MPO disease.
